Skip to main content

Clarus Corporation (CLAR) Stock Forecast

Data as of Aug 7, 2026

Consumer Cyclical · Current price $3.75 (+11.13%)

Consensus Target
$3.95
Upside
+23.8%
Analysts
3
Rating
Hold(2.67)

Price Target Range

Low $2.90Consensus $3.95High $5.00
▲ Current $3.75

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

No ratings in the last 3 months.
Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

CLAR vs Sector & Market

MetricCLARConsumer Cyclical AvgLarge Cap Avg
Analyst Rating2.672.502.42
Analyst Count31218
Target Upside+23.8%+133.4%+17.2%
P/E Ratio-2.2417.3535.26

Revenue Estimates

PeriodLowAvgHigh#
2026-09-30$71M$72M$73M2
2026-12-31$68M$69M$70M3
2027-03-31$61M$62M$63M3
2027-06-30$56M$57M$58M2
2027-09-30$73M$74M$75M2
2027-12-31$71M$72M$73M3
2028-12-31$286M$286M$286M1

EPS Estimates

PeriodLowAvgHigh#
2026-09-30$0.02$0.02$0.021
2026-12-31$0.02$0.02$0.021
2027-03-31$0.00$0.00$0.000
2027-06-30$0.00$0.00$0.000
2027-09-30$0.00$0.00$0.000
2027-12-31$0.00$0.00$0.000
2028-12-31$-0.08$-0.08$-0.081

Frequently Asked Questions

What is the analyst consensus for CLAR?

The consensus among 3 analysts covering Clarus Corporation (CLAR) is Hold with an average price target of $3.95.

What is the highest price target for CLAR?

The highest analyst price target for CLAR is $5.00.

What is the lowest price target for CLAR?

The lowest analyst price target for CLAR is $2.90.

How many analysts cover CLAR?

3 analysts have issued ratings for Clarus Corporation in the past 12 months.

Is CLAR a buy or sell right now?

Based on 3 analyst ratings, CLAR has a consensus rating of Hold (2.67/5) with a +23.8% upside to the consensus target of $3.95.

What are the earnings estimates for CLAR?

Analysts estimate CLAR will report EPS of $0.02 for the period ending 2026-09-30, with revenue estimated at $72M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.